BMO Capital Keeps Their Hold Rating on Teladoc (TDOC)
In a report released yesterday, Sean Dodge from BMO Capital maintained a Hold rating on Teladoc, with a price target of $5.00. The company’s shares closed yesterday at $4.65.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dodge covers the Healthcare sector, focusing on stocks such as Phreesia, Addus Homecare, and Icon. According to TipRanks, Dodge has an average return of -7.2% and a 40.08% success rate on recommended stocks.
Currently, the analyst consensus on Teladoc is a Hold with an average price target of $7.23, a 55.48% upside from current levels. In a report released today, TipRanks – Google also reiterated a Hold rating on the stock with a $4.50 price target.
Based on Teladoc’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $626.44 million and a GAAP net loss of $49.51 million. In comparison, last year the company earned a revenue of $640.51 million and had a GAAP net loss of $33.28 million
Read More on TDOC:
Disclaimer & DisclosureReport an Issue
- Teladoc price target lowered to $9 from $12 at Piper Sandler
- Teladoc price target lowered to $5 from $8 at Evercore ISI
- Teladoc price target lowered to $6 from $8 at Stifel
- Teladoc price target lowered to $6 from $8 at Wells Fargo
- Teladoc: Mixed Results, Structural Headwinds, and Below-Consensus Outlook Justify Neutral Stance
